The Milwaukee I-Corps Program kicks off its Winter 2018 cohort!

The Milwaukee I-Corps Program kicks off its Winter 2018 cohort with eight innovative teams. Funded by the National Science Foundation (NSF) Innovation Corps Program, the Southeastern Wisconsin I-Corps Site fosters commercialization of applied academic research and faculty/student innovation; build an innovation/commercialization network that supports faculty and/or student ventures; and broaden the pool of students and faculty fluent in Lean LaunchPad (LLP) methodology.

Entrepreneur and UWM researcher invent a virus ‘super-sensor’

Mail delivery to the wrong office in Milwaukee’s Global Water Center sparked a research partnership resulting in a super-sensor that is a finalist in the NASA iTech Challenge competition. Designed by David Rice of Rice Technology LLC and tested with UWM environmental engineer Marcia Silva, the sensor can quickly and inexpensively measure multiple contaminants in water, including viruses, which are so small they pass through bacterial filters. 

The $1 Water Sensor

Dr. Woo Jin Chang, Associate Professor, Mechanical Engineering, has developed a menu of miniature electrochemical sensors that can detect—at low-cost and instantaneously—heavy metals, water acidity, and nutrients in drinking water and other fluids. Three Wisconsin companies have licensed the sensor and now Chang and his co-inventor are collaborating with a California-based company to commercialize it.

New Milestone for LeanServ

Today, LeanServ reached a significant milestone in the development of one of its promising brands. We finalized and signed an Option Agreement with the Milwaukee Research Foundation. This is an important step for us. I want to thank everyone who believed in LeanVO's potential by...

Promentis Pharmaceuticals Commences Phase 1 Study for SXC-2023 Targeting Neuropsychiatric Disorders

Promentis Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing innovative therapies for neuropsychiatric disorders, today announced that it has commenced a Phase 1 single ascending dose study for its lead compound, SXC-2023. Promentis is developing SXC-2023 and other compounds that engage System xc-, a central nervous system (CNS) target addressing glutamatergic imbalance and oxidative stress, to treat obsessive-compulsive and related disorders, substance-related and addictive disorders and other neuropsychiatric disorders. SXC-2023 has demonstrated a compelling profile across a range of non-clinical studies.

Three winners awarded $20,000 at Healthcare Innovation Pitch competition

Three teams of entrepreneurs claimed a total of $60,000 in seed funding for their winning health care innovations at the Healthcare Innovation Pitch event held Wednesday as part of Milwaukee Startup Week. The winners were among 11 teams to pitch their health care innovations to a panel of venture capitalists in the Shark Tank-style event put on by Wauwatosa-based Bridge to Cures. Milwaukee Commissioner of Health Bevan Baker spoke at the Healthcare Innovation Pitch event at the Hilton Milwaukee City Center.

New Partnership with Shorewood School District to Spur “Authentic Learning”

The University of Wisconsin-Milwaukee’s (UWM) Lubar Entrepreneurship Center and the Shorewood School District have announced a new Teaching Fellows partnership to cultivate Authentic Learning in grades 7-12.  The new Fellows program, supported by a grant from the Shorewood SEED Foundation, will tap into UWM’s expertise and provide professional development for Shorewood teachers as they build new and innovative educational opportunities for students.